808 The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances responses to anti-PD-1 immunotherapy

808 The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances responses to anti-PD-1 immunotherapy

Bibliographic Details
Main Authors:	Patrick Hwu, Apoorvi Chaudhri, Ping Hua, Xia Bu, Michael A Davies, Yunfei Wang, Shao-Hsi Hung, Ulrich Von Andrian, Gordon Freeman, Gregory A Lizee
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances response to anti-PD-1 immunotherapy
by: Apoorvi Chaudhri, et al.
Published: (2023-09-01)

229 CX3CR1 in exhausted CD8 T cell states
by: Patrick Hwu, et al.
Published: (2021-11-01)

CX3CL1/CX3CR1 and CCL2/CCR2 chemokine/chemokine receptor complex in patients with AMD.
by: Mads Krüger Falk, et al.
Published: (2014-01-01)

The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders
by: Paulina Pawelec, et al.
Published: (2020-10-01)

Modulating neurotoxicity through CX3CL1/CX3CR1 signaling
by: Cristina eLimatola, et al.
Published: (2014-08-01)

Role of the CX3C chemokine receptor CX3CR1 in the pathogenesis of atherosclerosis after aortic transplantation.
by: Zuzanna Rowinska, et al.
Published: (2017-01-01)

Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1).
by: Lucas, A, et al.
Published: (2003)

High expression of CX3C chemokine receptor 1 (CX3CR1) in human carotid plaques is associated with vulnerability of the lesions
by: Marta Masztalewicz, et al.
Published: (2017-06-01)

Involvement of CX3CL1/CX3CR1 signaling in spinal long term potentiation.
by: Chao Bian, et al.
Published: (2015-01-01)

Hydrogen sulfide inhibits the development of atherosclerosis with suppressing CX3CR1 and CX3CL1 expression.
by: Huili Zhang, et al.
Published: (2012-01-01)

CCL2/CCR2 and CX3CL1/CX3CR1 chemokine axes and their possible involvement in age-related macular degeneration
by: Camelo Serge, et al.
Published: (2010-12-01)

Pharmacological depletion of microglia alleviates neuronal and vascular damage in the diabetic CX3CR1-WT retina but not in CX3CR1-KO or hCX3CR1I249/M280-expressing retina
by: Kaira A. Church, et al.
Published: (2023-03-01)

Modulation of microglia activation and Alzheimer's disease: CX3 chemokine ligand 1/CX3CR and P2X7R signaling
by: Pavithra Suresh, et al.
Published: (2021-01-01)

Microglia, seen from the CX3CR1 angle
by: Yochai eWolf, et al.
Published: (2013-03-01)

Cochlear resident macrophage mediates development of ribbon synapses via CX3CR1/CX3CL1 axis
by: Xinyu Song, et al.
Published: (2022-11-01)

Tenophages: a novel macrophage-like tendon cell population expressing CX3CL1 and CX3CR1
by: Christine Lehner, et al.
Published: (2019-12-01)

Differential modulation of retinal degeneration by Ccl2 and Cx3cr1 chemokine signalling.
by: Luhmann, U, et al.
Published: (2012)

VHH antibody targeting the chemokine receptor CX3CR1 inhibits progression of atherosclerosis
by: Sarah Low, et al.
Published: (2020-01-01)

Differential modulation of retinal degeneration by Ccl2 and Cx3cr1 chemokine signalling.
by: Ulrich F O Luhmann, et al.
Published: (2012-01-01)

Research advances of chemokine receptor CX3CR1 and microglia in retinal degenerative diseases
by: Yu-Lin Qi, et al.
Published: (2021-08-01)

CX3CL1/CX3CR1 signal mediates M1-type microglia and accelerates high-altitude-induced forgetting
by: Xueting Wang, et al.
Published: (2023-05-01)

A double-edged sword: interactions of CX3CL1/CX3CR1 and gut microbiota in systemic lupus erythematosus
by: Rana A. Estaleen, et al.
Published: (2024-01-01)

Correction: CX3CR1 Is Expressed by Human B Lymphocytes and Mediates CX3CL1 Driven Chemotaxis of Tonsil Centrocytes
Published: (2010-01-01)

CX3CR1 is expressed by human B lymphocytes and mediates [corrected] CX3CL1 driven chemotaxis of tonsil centrocytes.
by: Anna Corcione, et al.
Published: (2009-12-01)

Early activation of the cardiac CX3CL1/CX3CR1 axis delays β-adrenergic-induced heart failure
by: M. Flamant, et al.
Published: (2021-09-01)

Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease?
by: Sarah Cormican, et al.
Published: (2021-06-01)

Cx3cr1 controls kidney resident macrophage heterogeneity
by: Alex Yashchenko, et al.
Published: (2023-05-01)

Absence of CX3CR1 impairs the internalization of Tau by microglia
by: Marta Bolós, et al.
Published: (2017-08-01)

Fractalkine/CX3CR1 signalling during neuropathic pain
by: Anna K Clark, et al.
Published: (2014-05-01)

Fractalkine/CX3CR1 Pathway in Neuropathic Pain: An Update
by: Rita Silva, et al.
Published: (2021-07-01)

An overlooked subset of Cx3cr1 wt/wt microglia in the Cx3cr1 CreER-Eyfp/wt mouse has a repopulation advantage over Cx3cr1 CreER-Eyfp/wt microglia following microglial depletion
by: Kai Zhou, et al.
Published: (2022-01-01)

Deciphering the role of CX3CL1-CX3CR1 in aortic aneurysm pathogenesis: insights from Mendelian randomization and transcriptomic analyses
by: Xingyu Qian, et al.
Published: (2024-04-01)

CX3CL1 and its receptor CX3CR1 interact with RhoA signaling to induce paclitaxel resistance in gastric cancer
by: Xiangyang Liu, et al.
Published: (2024-04-01)

Effect of CX3CL1/CX3CR1 gene polymorphisms on the clinical efficacy of carboplatin therapy in Han patients with ovarian cancer
by: Xin-Chen Wang, et al.
Published: (2023-01-01)

The Interplay of Cx26, Cx32, Cx37, Cx40, Cx43, Cx45, and Panx1 in Inner-Ear Development of Yotari (dab1−/−) Mice and Humans
by: Josip Lesko, et al.
Published: (2022-03-01)

The role of the CX3CL1/CX3CR1 axis as potential inflammatory biomarkers in subjects with periodontitis and rheumatoid arthritis: A systematic review
by: Mario A. Alarcón‐Sánchez, et al.
Published: (2024-02-01)

Fractalkine Signalling (CX<sub>3</sub>CL1/CX<sub>3</sub>CR1 Axis) as an Emerging Target in Coronary Artery Disease
by: Shu Xian Loh, et al.
Published: (2023-07-01)

Platelets are recruited to hepatocellular carcinoma tissues in a CX3CL1‐CX3CR1 dependent manner and induce tumour cell apoptosis
by: Shuo Miao, et al.
Published: (2020-10-01)

CX3CR1 knockout aggravates Coxsackievirus B3-induced myocarditis.
by: Irene Müller, et al.
Published: (2017-01-01)

CX3CR1 signaling on monocytes is dispensable after intracerebral hemorrhage.
by: Roslyn A Taylor, et al.
Published: (2014-01-01)